JP2008500376A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500376A5
JP2008500376A5 JP2007517026A JP2007517026A JP2008500376A5 JP 2008500376 A5 JP2008500376 A5 JP 2008500376A5 JP 2007517026 A JP2007517026 A JP 2007517026A JP 2007517026 A JP2007517026 A JP 2007517026A JP 2008500376 A5 JP2008500376 A5 JP 2008500376A5
Authority
JP
Japan
Prior art keywords
composition
use according
cryptoxanthin
muscle cells
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007517026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500376A (ja
JP5145035B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/005030 external-priority patent/WO2005110122A1/en
Publication of JP2008500376A publication Critical patent/JP2008500376A/ja
Publication of JP2008500376A5 publication Critical patent/JP2008500376A5/ja
Application granted granted Critical
Publication of JP5145035B2 publication Critical patent/JP5145035B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007517026A 2004-05-18 2005-05-10 β−クリプトキサンチンの使用 Expired - Fee Related JP5145035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04011743 2004-05-18
EP04.011743.4 2004-05-18
PCT/EP2005/005030 WO2005110122A1 (en) 2004-05-18 2005-05-10 USE OF β-CRYPTOXANTHIN

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012203513A Division JP2013047227A (ja) 2004-05-18 2012-09-14 β−クリプトキサンチンの使用

Publications (3)

Publication Number Publication Date
JP2008500376A JP2008500376A (ja) 2008-01-10
JP2008500376A5 true JP2008500376A5 (https=) 2011-11-17
JP5145035B2 JP5145035B2 (ja) 2013-02-13

Family

ID=34966671

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007517026A Expired - Fee Related JP5145035B2 (ja) 2004-05-18 2005-05-10 β−クリプトキサンチンの使用
JP2012203513A Pending JP2013047227A (ja) 2004-05-18 2012-09-14 β−クリプトキサンチンの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012203513A Pending JP2013047227A (ja) 2004-05-18 2012-09-14 β−クリプトキサンチンの使用

Country Status (9)

Country Link
US (1) US20080070980A1 (https=)
EP (1) EP1748705B1 (https=)
JP (2) JP5145035B2 (https=)
KR (1) KR101317976B1 (https=)
CN (1) CN1953669B (https=)
AT (1) ATE484201T1 (https=)
DE (1) DE602005024128D1 (https=)
ES (1) ES2351701T3 (https=)
WO (1) WO2005110122A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013219A1 (fr) * 2006-07-28 2008-01-31 Unitika Ltd. Composition orale permettant une absorption accrue de la cryptoxanthine
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5688697B2 (ja) * 2009-09-25 2015-03-25 国立大学法人愛媛大学 免疫蛋白質の産生促進剤
JP5909084B2 (ja) * 2010-12-15 2016-04-26 アークレイ株式会社 安定化βクリプトキサンチン含有水およびその用途
CN102219721B (zh) * 2011-04-02 2013-08-07 秦皇岛大惠生物技术有限公司 一种含有β-隐黄质的浓缩物的提取方法与采用该方法所得到的浓缩物及其用途
US20140221487A1 (en) * 2011-07-13 2014-08-07 University Of Georgia Research Foundation, Inc Use Of Xanthophyll Carotenoids To Improve Visual Performance And Neural Efficiency
ES2694426T3 (es) * 2012-10-04 2018-12-20 Abbott Laboratories Procedimientos para mejorar el efecto de EGCg en la mitigación de la pérdida de músculo esquelético
JP5687682B2 (ja) * 2012-12-20 2015-03-18 ユニチカ株式会社 カルシウム吸収促進組成物
KR20150129680A (ko) 2013-01-24 2015-11-20 옴니액티브 헬스 테크놀로지스 리미티드 식물 공급원 유래 베타-크립토잔틴 및 이의 제조 방법
US20160106776A1 (en) * 2013-05-31 2016-04-21 Dsm Ip Assets B.V. Feed supplement and its use
BR112017015209A2 (pt) * 2015-01-15 2018-06-26 Dsm Ip Assets Bv Alimento para aves domésticas com combinação de 25-hidroxi-vitamina d e antioxidantes/anti- inflamatórios
EP3300474A4 (en) 2015-04-27 2019-01-30 OmniActive Health Technologies Limited BETTUBO TOXIN COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF
CN104906112B (zh) * 2015-05-20 2018-02-23 杨克西 一种促进蛋白质合成的组合物及其制备方法和用途
JP2019218316A (ja) * 2018-06-21 2019-12-26 公立大学法人大阪 オートファジー活性向上剤
SG10201900604TA (en) 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
WO2022018161A1 (en) 2020-07-22 2022-01-27 Dsm Ip Assets B.V. Beta-cryptoxanthin crystal forms, liquid formulations thereof and processes for their manufacture
WO2022018162A1 (en) 2020-07-22 2022-01-27 Dsm Ip Assets B.V. FORMULATIONS OF NEW β-CRYPTOXANTHIN CRYSTAL FORM, PROCESSES FOR THEIR MANUFACTURE AND THEIR USES
CN115530381A (zh) * 2022-08-17 2022-12-30 中南大学 预防产前抑郁症的蛋白粉及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
US8148431B2 (en) * 2002-10-25 2012-04-03 Kemin Health, L.C. Osteogenesis promoter containing β-cryptoxanthin as the active ingredient

Similar Documents

Publication Publication Date Title
JP2008500376A5 (https=)
US9937198B2 (en) Multi-functional composition and preparation method and application thereof
Ternak Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution?
KR20170142756A (ko) 굼벵이를 포함하는 간 및 혈액순환 개선용 조성물 및 그 제조방법
CN107549113A (zh) 一种梅花鹿的养殖方法
JP2009051775A (ja) 持久力増強剤および抗疲労剤
JP2011157302A (ja) 深部体温正常化剤および体温正常化組成物
WO2006013427A3 (en) Treatment of ccr2 mediated diseases or disorders
Saunders Veterinary care of chinchillas
JP2006197911A (ja) 蜂の子利用の健康食品。
JP2005521426A5 (https=)
Firyal et al. Elephant as a veterinary patient
RU2004109902A (ru) Лечебный корм для рыб
US20090176871A1 (en) Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones
Kumar et al. Indigenous livestock practices of tribal farmers
Shojai New Choices in Natural Healing for Dogs and Cats
Panigrahi Conservative treatment of hip dysplasia in a Labrador dog-A case study
JP2005200390A (ja) 持久力増強剤および抗疲労剤
RU2000126035A (ru) Способ лечения и профилактики железодефицитной анемии у сельскохозяйственных животных
JP2003246728A5 (https=)
Floyd et al. General Supportive Care for the Laminitis Case
KR101303925B1 (ko) 숯을 이용한 가축의 설사 예방 및 치료용 조성물
K'Eogh Zoologia Medicinalis Hibernica: Or, a Treatise of Birds, Beasts, Fishes, Reptiles, Or Insects, which are Commonly Known and Propagated in this Kingdom:... By John K'eogh,...
RU2067860C1 (ru) Способ лечения постнатальной гипотрофии поросят
Doyle et al. Donkeys